NMTT- Neuroblastoma Maintenance Therapy Trial Using DFMO

The purpose of this research study is to evaluate an investigational drug, called DFMO, for neuroblastoma that is in remission. An investigational drug is one that has not been approved by the U.S. Food and Drug Administration (FDA). This study will look at the ability of this study drug to keep your tumor in remission and will also look at the safety and tolerability of DFMO. DFMO was shown to be effective in inhibiting tumor growth in adult colon cancers. DFMO has been tested in multiple adult and pediatric clinical trials. Previous studies and laboratory testing in neuroblastoma suggests that this drug may be effective in preventing relapse of this disease.

June 03, 2016